GlassScriptPhysician profile
Thomas Walter Moore
NPI 1689803611
$6,071.68
in general payments reported to CMS, 2019-2025
16 companies · $685 in 2025
The $685 reported for 2025 was more than what 84% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,889 · 2020: $220 · 2021: $800 · 2022: $508 · 2023: $918 · 2024: $1,051 · 2025: $685.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,655.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,654.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb, A Division of Bausch Health US, LLC | $1,789.27 | 2019-2021 | |
| Alcon Vision LLC | $1,105.95 | 2019-2025 | Total30, Dailies, Dailies Total1 |
| Bausch & Lomb Americas INC. | $1,076.47 | 2022-2025 | Infuse, Miebo, Xiidra |
| Sun Pharmaceutical Industries INC. | $597.86 | 2019-2025 | Cequa |
| Allergan, INC. | $285.92 | 2021-2022 | |
| Coopervision INC. | $262.76 | 2022-2025 | Myday Contact Lens, Biofinity Contact Lens |
| Abbvie INC. | $235.49 | 2022-2023 | |
| Lkc Technologies, INC. | $221.48 | 2023-2024 | |
| Topcon Healthcare, INC. | $181.43 | 2025 | |
| Dompe US, INC. | $136.89 | 2024-2025 | Oxervate |
| Oyster Point Pharma, INC. | $65.13 | 2022-2024 | Tyrvaya |
| Kala Pharmaceuticals, INC. | $43.77 | 2021 | |
| Novartis Pharmaceuticals Corporation | $22.27 | 2021 | |
| Optos, INC. | $18.61 | 2020 | |
| Shire North American Group INC | $14.40 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Maculogix, INC. | $13.98 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Moore listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.